MedPath

Atamestane

Generic Name
Atamestane
Drug Type
Small Molecule
Chemical Formula
C20H26O2
CAS Number
96301-34-7
Unique Ingredient Identifier
62GA3K28B6

Overview

Atamestane has been used in trials studying the treatment of Breast Cancer, Breast Neoplasms, and Neoplasms, Hormone-Dependent.

Background

Atamestane has been used in trials studying the treatment of Breast Cancer, Breast Neoplasms, and Neoplasms, Hormone-Dependent.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath